Protagenic Therapeutics, Inc.\new (PTIX) Shares Outstanding (Diluted) (2013 - 2026)
Protagenic Therapeutics, Inc.\new's Shares Outstanding (Diluted) came in at 1.81 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 51.1% from 3.7 million a year earlier and down 22.3% from the prior quarter.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.\new's Shares Outstanding (Diluted) was 2.33 million, up 345.2% from FY2025.
- Shares Outstanding (Diluted) carries a five-year compound annual growth rate of -20.1% (FY2021 to FY2026).
- Going back by fiscal year, Shares Outstanding (Diluted) was 523,185 in FY2025, 5.4 million in FY2024, 310,333 in FY2023 (+0.6%) and 308,426 in FY2022 (-95.7%).
- The fiscal Q1 2027 figure represents the lowest quarterly Shares Outstanding (Diluted) since fiscal Q4 2025.
- Business Quant data shows PTIX's Shares Outstanding (Diluted) at 2.33 million (Q4 2026), 1.93 million (Q3 2026) and 1.85 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.36 Mn | 1.36 Mn | - | 1.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 523,185.00 |
| Dec 31, 2024 | 5.40 Mn |
| Sep 30, 2024 | 323,513.00 |
| Jun 30, 2024 | 317,381.00 |
| Mar 31, 2024 | 316,801.00 |
| Dec 31, 2023 | 310,333.00 |
| Sep 30, 2023 | 309,360.00 |
| Jun 30, 2023 | 309,360.00 |
| Mar 31, 2023 | 308,426.00 |
| Dec 31, 2022 | 308,426.00 |
| Sep 30, 2022 | 308,672.00 |
| Jun 30, 2022 | 308,590.00 |
| Mar 31, 2022 | 7.14 Mn |
| Dec 31, 2021 | 7.14 Mn |
| Sep 30, 2021 | 7.14 Mn |
API Access
Protagenic Therapeutics, Inc.\new Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();